Mark Baldry serves as Executive at AMICUS THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Mark Baldry has executed 5 insider transactions totaling $7.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 1, 2023 involved selling 10,257 shares valued at $7.5K.
Mark Baldry currently holds 24,690 shares of AMICUS THERAPEUTICS INC (FOLD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Baldry has been a net seller of FOLD stock. They have purchased $0 and sold $7.5K worth of shares.
Mark Baldry's most recent insider trade was on Nov 1, 2023, when they sold 10,257 shares at $0.73 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 5, 2019 | WVE | $0 | Award | 4,000 | $N/A | Discretionary |
| Aug 5, 2019 | WVE | $0 | Award | 35,000 | $N/A | Discretionary |
| Jun 1, 2015 | FOLD | $0 | Award | 25,000 | $N/A | Discretionary |